📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Potential of the Cardiovascular Drug Levosimendan in the Management of Amyotrophic Lateral Sclerosis: An Overview of a Working Hypothesis. (2019)

First Author: Al-Chalabi A

Attributed to: STRENGTH funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/fjc.0000000000000728

PubMed Identifier: 31730560

Publication URI: http://europepmc.org/abstract/MED/31730560

Type: Journal Article/Review

Volume: 74

Parent Publication: Journal of cardiovascular pharmacology

Issue: 5

ISSN: 0160-2446